DebraLRichardsonMD
Obstetrics & Gynecology • Oklahoma City, OKGynecologic Oncology
Associate Professor, Gynecologic Oncology at Stephenson Cancer Center
Dr. Richardson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 NE 10th St
Oklahoma City, OK 73104Phone+1 405-271-7770
Education & Training
Ohio State University/Mt Carmel HospitalFellowship, Gynecologic Oncology, 2006 - 2009
University of ConnecticutResidency, Obstetrics and Gynecology, 2001 - 2005
New York Medical CollegeClass of 2001
Certifications & Licensure
OK State Medical License 2017 - 2025
TX State Medical License 2009 - 2020
MN State Medical License 2005 - 2011
OH State Medical License 2006 - 2009- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer Start of enrollment: 2020 Jun 29
Roles: Contact
- A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. Start of enrollment: 2022 Jul 25
Roles: Principal Investigator
- Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) Start of enrollment: 2022 Aug 31
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- 204 citationsSociety of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositionsJohnathan M. Lancaster, C. Bethan Powell, Lee-may Chen, Debra L. Richardson
Gynecologic Oncology. 2015-01-01 - 38 citationsAddition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer.David M. O'Malley, Debra L. Richardson, Patrick S. Rheaume, Ritu Salani, Eric L. Eisenhauer
Gynecologic Oncology. 2011-05-01 - 84 citationsRobotic hysterectomy and pelvic-aortic lymphadenectomy for endometrial cancer.Leigh G. Seamon, David E. Cohn, Debra L. Richardson, Sue Valmadre, Matthew Carlson
Obstetrics and Gynecology. 2008-12-01
Press Mentions
Mersana Therapeutics to Provide Update on the Progress of Its UpRi Clinical Development Strategy and Report Interim Data from the Ovarian Cancer Expansion Cohort of the UpRi Phase I StudySeptember 1st, 2021- Sarah Cannon to Present Latest Cancer Research Insights at 2021 ASCO® Annual MeetingJune 4th, 2021
- Group Is Established to Connect, Inspire and Empower UCI Women in TechnologyAugust 12th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
